Modeling Transmission Dynamics and Control of Vector-Borne Neglected Tropical Diseases by Luz, Paula M. et al.
Review
Modeling Transmission Dynamics and Control of Vector-
Borne Neglected Tropical Diseases
Paula M. Luz
1,2*, Claudio J. Struchiner
3, Alison P. Galvani
1
1School of Public Health, Yale University, New Haven, Connecticut, United States of America, 2Instituto de Pesquisa Clinica Evandro Chagas, Fundacao Oswaldo Cruz,
Manguinhos, Rio de Janeiro, Rio de Janeiro, Brasil, 3Programa de Computacao Cientifica, Fundacao Oswaldo Cruz, Manguinhos, Rio de Janeiro, Rio de Janeiro, Brasil
Abstract: Neglected tropical diseases affect more than
one billion people worldwide. The populations most
impacted by such diseases a r et y p i c a l l yt h em o s t
resource-limited. Mathematical modeling of disease trans-
mission and cost-effectiveness analyses can play a central
role in maximizing the utility of limited resources for
neglected tropical diseases. We review the contributions
that mathematical modeling has made to optimizing
intervention strategies of vector-borne neglected diseas-
es. We propose directions forward in the modeling of
these diseases, including integrating new knowledge of
vector and pathogen ecology, incorporating evolutionary
responses to interventions, and expanding the scope of
sensitivity analysis in order to achieve robust results.
Introduction
Mathematical modeling of vector-borne infectious diseases
originated with Sir Ronald Ross’s study of malaria transmission
in 1916 [1]. Ross recognized that vector-borne infections are
governed by nonlinear dynamics, which makes intuitive assess-
ment of the natural trajectory of an epidemic and intervention
effectiveness difficult, if not impossible, without mathematical
modeling. Mathematical models can play important roles in the
study of infectious diseases. Models help explain the dynamics of
an infectious disease within a host or a population, and they
facilitate comparisons among competing control strategies that can
inform policy decisions.
The use of mathematical models has been gaining momentum
in recent decades. Models are being used to address an ever-
expanding number of diseases and public health questions, as well
as to explore the importance of biological and ecological details on
disease transmission [2]. For example, to realistically incorporate
the population dynamics of mosquitoes, there is a need to take into
account age structure, seasonality, and density-dependent mortal-
ity [3–5]. The realistic incorporation of vectors then improves the
evaluation of the long-term impact of control strategies [6,7]. In
this review, we address model parameterization and sensitivity
analysis, two important steps in the building and analysis of
mathematical models. We discuss specific features of neglected
vector-borne diseases that should be incorporated into quantitative
methods that analyze control strategies for such diseases. We also
review the areas in which models have been and can be most
useful, including drug, vaccine, vector, and alternative control
strategies, as well as cost-effectiveness analysis.
Methods
We searched PubMed, Web of Science, and SciELO using the
terms ‘‘mathematical model’’, ‘‘modeling’’, ‘‘cost-effectiveness
analysis’’, and ‘‘economic analysis’’. For the theoretical literature,
we included studies that, in our opinion, addressed important
technicalities of mathematical models applied to infectious
diseases, including, for example, dynamic modeling, sensitivity
analysis, and cost-effectiveness analysis. Modeling analyses con-
ducted for diseases not considered to be neglected vector-borne
diseases were excluded. We report on studies that evaluate the
impact of interventions on vector-borne neglected tropical
diseases.
Basic Model Development, Parameterization, and
Sensitivity Analyses
Model development involves several steps and considerations.
Once the modeler identifies the essential components of the
biological processes necessary to address the questions of interest,
the information needs to be translated into equations that describe
the transmission dynamics. The most popular mathematical model
is the SIR model, which divides hosts into compartments on the
basis of whether they are susceptible, infectious, or recovered/
immune (Figure 1). A susceptible individual (S) who contracts
disease becomes infectious (I) and then recovers (R) to become
immune. The parameters of the SIR model are the rate at which
susceptible hosts become infected (b) and the rate at which
infectious individuals recover (c). For vector-borne diseases, the
rate at which hosts become infected (b) depends on vector
competence and abundance.
Model parameterization can be achieved using published
studies and from fitting a model to observed data [2]. As
parameter values are only estimates of ‘‘true’’ values [8], modelers
need to perform sensitivity analysis in order to explore which
parameters have the greatest impact on model predictions.
Different approaches to sensitivity analysis vary in their simplicity
and applicability to specific models. Univariate sensitivity analysis
measures the impact of the variation of one parameter on the
outcome of the model while all other parameters are held constant.
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change the value of each model parameter by a certain percent,
and then measure the percent change in the value of the outcome.
Such sensitivity analysis can be represented on a tornado plot,
which is a graphical way of showing which parameters most
strongly influence the outcome of a model [9]. For vector-borne
diseases, it is common that demographic parameters, such as the
vector’s life span and reproductive capacity, have the greatest
impact on the population dynamics of the vector. For example, the
mortality rate of a vector usually has a particularly pronounced
influence on disease transmission [10].
Multivariate sensitivity analysis consists of simultaneously mea-
suring the impact of multiple parameters. One approach for
multivariate sensitivity analysis is through Monte Carlo simulations.
For this procedure, probability distributions are assigned to
parameters and the values of those parameters are sampled
repeatedly from these distributions. Model simulations with each
set of these parameters are then computed to generate a distribution
ofmodeloutcomesfromwhichsummarystatisticscanbecalculated.
Statistical regression models can then be used to determine which
parameters most strongly influence model outcome [11].
Current Public Health Challenges Addressed by
Models of Vector-Borne Diseases
Mathematical models and cost-effectiveness analysis have been
used to assess the impact of various control strategies for a wide
range of neglected tropical diseases, which we review here.
Maximizing Drug Utility
Many neglected vector-borne diseases can be treated and
controlled with drugs [12]. However, this control strategy imposes
Figure 1. SIR model. Schematic representation, differential equations, and plot for the basic SIR (susceptible, infectious, and recovered) model.
Model parameters are b, the transmission rate (b=0.0005), and c, the recovery rate (c=0.05). There is initially one infection in a population of 1,000
individuals.
doi:10.1371/journal.pntd.0000761.g001
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utility, such evolutionary consequences should be taken into
account. Currently, several vector control programs advocate
widespread administration of drugs to avoid mass screening for
detection of infected individuals, because diagnostic tests can be
costly and imperfect [15]. However, mass administration of drugs
results in the unnecessary treatment of uninfected individuals, a
practice leading to higher rates of adverse effects and faster
selection for drug resistance [16]. For example, the dilemma of
mass versus targeted drug administration for onchocerciasis, a
disease usually treated with the drug ivermectin, has been explored
using a model that incorporates heterogeneity in human exposure
[16]. It was found that targeted ivermectin interventions can
reduce the onchocerciasis health burden using only 20%–25% of
the doses required for mass drug administration, thus resulting in
decreased costs, a smaller proportion of adverse effects, and a
lower probability of spread of ivermectin resistance [16]. This
example illustrates the positive impact on treatment approaches
that modeling public health interventions can have to reduce both
the spread of disease and the development of resistance.
Vector Control
Vector control [12], which relies on the use of insecticides, is the
primary control method of neglected vector-borne diseases. The
basic reproduction number (R0) is the number of secondary
infections generated from a single infected individual introduced
into a susceptible population. In order to curtail transmission,
vector control efforts need to decrease the value of R0 below the
critical value of 1. For example, R0 was used to determine the
extent of vector control necessary to eliminate the transmission of
Chagas disease in Brazil [17]. Given that the R0 for Chagas disease
in Brazil is 1.25, it was shown that a 25% increase in vector control
mortality induced by insecticides was sufficient to reduce R0 below
1. Nonetheless, a differential equation model showed that a vector
control strategy that reduced R0 just below 1 would require more
than half a century to achieve disease eradication due to disease
persistence in chronically infected individuals.
Two models incorporating vector control have also evaluated
insecticide-based vector control strategies for dengue prevention
[18,19]. The estimated impact of vector control on dengue cases
differs between the two studies due to different model assumptions
regarding the seasonality of dengue transmission. When season-
ality is not incorporated, control of adult mosquitoes is predicted
to delay but not eliminate dengue epidemics. Thus, ultimately,
vector control is predicted to have little impact on dengue
incidence [19]. In contrast, when seasonality is incorporated,
control of adult mosquitoes is found to be the most effective
strategy to curtail an ongoing epidemic [18]. This highlights the
general phenomenon that the omission of fundamental biological
realism can significantly affect model predictions.
Field evaluations have shown that resistance evolution currently
threatens dengue vector control strategies [20]. A mathematical
model of seasonal Aedes aegypti population dynamics that
incorporates population genetics has been used [21] to estimate
the impact of insecticide-based vector control interventions.
Considering both the impact of interventions on mosquito
abundance and on the evolutionary trajectory of resistance, it
was found that optimal interventions combine vector control at
both larval and adult stages and are applied only during the
dengue season.
Vaccine Delivery and Coverage
One of the most significant obstacles to the implementation of
optimal vaccination policies is public adherence to recommenda-
tions. Concerns about risks of vaccinations, whether real or
perceived [22–25], affect vaccination decisions. A burgeoning area
for the application of models has been the prediction of likely
adherence to different recommendations, particularly with regard
to designing strategies to promote optimal vaccination recom-
mendations. Models can be used to analyze both public health
policy and individual perspectives on a vaccination policy, such as
in the case of mosquito-borne yellow fever [26,27]. Sylvatic yellow
fever affects most of the north and central-west regions of Brazil.
The coastal area of Brazil, where the majority of the population
lives, is infested with the vector that transmits urban yellow fever,
posing a risk of an urban yellow fever outbreak. In recent years,
several reports of yellow fever vaccine-related adverse events have
generated public concern about the safety of the vaccine [28]. The
risk of a vaccine-related adverse fatal event versus the risk of an
urban outbreak poses a dilemma for vaccination policies in areas
to which yellow fever has not yet spread.
When the risk of serious adverse events from vaccination and
infection were taken into account, actual vaccination levels were
predicted to be lower than the vaccination levels required to
prevent an outbreak [27]. From the individual perspective, the
decision of whether to vaccinate becomes a function of how
prepared the public health authorities are for an urban outbreak
[26]. If preparedness is high, the optimal strategy for the individual
is to wait for an outbreak to actually occur before getting
vaccinated. However, the choice to vaccinate before an outbreak
becomes a better strategy as the likelihood of an outbreak increases
[26].
New and Alternative Interventions
Models can be used to evaluate the benefit of innovative control
strategies before devoting resources to the actual development and
implementation. For example, a mathematical model of oncho-
cerciasis transmission was used to evaluate the impact of a
hypothetical macrofilaricidal drug [29]. It was predicted that the
hypothetical drug would increase the potential for onchocerciasis
elimination compared to ivermectin, the drug currently in use.
However, depending on the epidemiological scenario of a
particular setting, high treatment coverage would still be needed
[29].
Other studies have assessed the potential impact of zooprophy-
laxis interventions, that is, the use of animals resistant against
disease to divert bites from humans, with regard to the household
transmission of Chagas disease [30]. The model considers the
vector, other domestic animals, and age structure in the human
population within the household. It was found that increasing the
domiciliary chicken population would not impact human preva-
lence rates significantly. Conversely, the exclusion of other
infectious vertebrates, especially infected dogs, from the domestic
environment can effectively reduce the human prevalence rate
[30].
Another promising avenue for the control of vector-borne
disease is through the genetic manipulation of vectors, an
approach that could be used synergistically with current control
strategies [31]. Genetic methods for controlling vector transmis-
sion are designed to reduce or eliminate vector populations, to
selectively kill only infected vectors, or to modify (or replace)
natural vector populations by introgressing genes that hamper
vector competence.
Transgenic strategies can be categorized as strategies that block
transmission, either from humans to mosquitoes or from
mosquitoes to humans; strategies that reduce mosquito biting by
interfering with host-seeking behavior; strategies that raise overall
mosquito mortality, i.e., through the release of engineered males
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raise mosquito infection-induced mortality, i.e., lethal genes only
expressed in the presence of infection. The evolutionary impact of
these different transgenic strategies must be incorporated to fully
evaluate the benefits, risks, and research priorities associated with
using genetically manipulated insects to control vector-borne
diseases [32]. Despite their promise as new tools to reduce disease
transmission, these interventions select for changes in pathogen
virulence to both the human and mosquito hosts, and their
evolutionary impact remains to be explored. Modeling has shown
that transgenic strategies based on blocking transmission or
reducing mosquito biting could select for increased disease
virulence to humans [33]. By contrast, strategies that increase
mosquito mortality do not select for changes in virulence to
humans [33].
Combined Interventions
Given that pathogens rapidly evolve to evade interventions, the
greatest promise for successful long-term control of vector-borne
disease may be a combined approach. The optimal combination of
control strategies can be assessed with mathematical models. The
dynamic aspect of all infectious diseases lends itself to adaptive
responses, which may translate into different optimal combina-
tions of interventions in different locations or at different times.
A modeling study evaluated the duration of mass treatment,
drug coverage, the added benefit of vector control, and the
possibility of resistance to drugs used in the mass drug
administration program for the control of lymphatic filariasis
[34]. It was found that in areas where the disease is highly
endemic, adding vector control to the mass drug administration
program greatly increases the speed at which control is attained.
There are synergistic benefits of using both mass drug adminis-
tration and vector control, because the former affects current
infections while the latter prevents new infections [34].
A more complex model incorporating host age-structured and
vector transmission dynamics was used to estimate the impact of
intervention strategies that consider two community-based inter-
ventions for filariasis control, vector control, and/or single-dose
mass chemotherapy [35]. Vector control was simulated by
reducing the biting rate, leading to a gradual decrease in human
infection levels. By incorporating host age-structure, the impact of
vector control on averting infections in the youngest age groups
was estimated. Chemotherapeutic interventions were predicted to
reduce both the prevalence and intensity of infection. After
cessation of treatment, recovery of infection levels depended on
the anti-filarial drug used, the two most common being
diethylcarbamazine citrate and ivermectin. Diethylcarbamazine
citrate, which kills significantly more adult worms than ivermectin,
achieved a longer suppression in prevalence. These results
highlight the importance of considering the macrofilaricidal
activity of drugs when designing control programs, because
macrofilaricidal activity determines the transmission dynamics
after program interruption [35]. Additionally, a small benefit is
gained from adding ivermectin to a macrofilaricidal drug, a
finding that has implications for current suggestions of strategies
based on ivermectin combined with the macrofilaricidal albenda-
zole [35].
Cost-Effectiveness Analysis
Traditional cost-effectiveness analyses that compare the relative
costs and effects of competing health interventions have been
conducted for some neglected vector-borne diseases. For example,
vector control of Chagas disease through residual spraying was
shown to be highly cost-effective in Guatemala [36]. Another
study compared the relative cost-effectiveness of different imple-
mentation methods (vertical, horizontal, or mixed) to reveal that
the mixed strategy was optimal [37]. Extensions regarding the
impact of residual spraying on resistance evolution or the impact
of different insecticide delivery schemes on vector control are
warranted to more fully evaluate long-term consequences of
interventions.
Other examples of traditional cost-effectiveness studies are the
analyses of drug schemes and of diagnostic/therapeutic strategies
that were assessed for visceral leishmaniasis [38,39]. Using a
decision analysis model, the optimal strategy for the identification
of diseased individuals and their treatment was evaluated for
regions where leishmaniasis is endemic [39]. It was shown that the
cost of the drug determines the optimal strategy [39]. Future
research could address the impact of resistance evolution or the
potential benefit of combined drug interventions [38].
A traditional cost-effectiveness analysis of vector control
interventions has also been carried out for dengue in urban areas
of Cambodia. Insecticide-based larval control performed twice a
year was found to be cost-effective in reducing dengue burden
[40]. Interestingly, there was no statistical difference in the
effectiveness obtained in areas with two rounds of larval control
compared to areas with one round of larval control, implying that
potentially less insecticide could be used to prevent dengue in that
setting, which would also conserve resources and reduce resistance
[41].
Limitations, Challenges, and Future Directions
We have come a long way since Ronald Ross’s early seminal
work. However, the increasing availability of complex data poses
additional challenges regarding their efficient use by expanding
the modeler’s horizons into new micro and macro model
structures. Recent advances in molecular biology and genetics
provide new tools to monitor micro diversity among pathogens
and vertebrate and invertebrate hosts. On the other extreme,
spatial and social dimensions push the limits of heterogeneities at
the macro level. Although macro heterogeneity has received more
attention in the past from modelers [42] than micro heterogeneity,
current population dynamics paradigms seem ill-equipped to make
appropriate predictions in this context and need to be expanded.
Formal logical frameworks that explicitly address both data
complexities by expanding the notions of efficacy of control
measures become necessary since they help in understanding the
various contributions of each component to the summary
measures of efficacy.
Complex models, where spatial structure, seasonal ‘‘forcing’’,
and/or stochasticity influence the dynamics and the impact of
interventions, and where computer simulation needs to be used to
generate theory, must be reliable and precise in order to be trusted
by the scientific community. Improvements in model sensitivity
analysis, validation and diagnostics against independent data, and
the availability of alternative model fitting techniques based on
Monte Carlo or resampling methods, along with the power of
today’s computing platforms, are expected to fulfill the demand for
formal estimation procedures of confidence intervals for model
parameters and predictions [43,44]. Progress in these areas will
help consolidate the partnership between modelers and empiri-
cists, including experts in the disease system of interest, providers
of epidemiological data, and those responsible for policy decisions.
The title of Joel Cohen’s recent paper [45] captures the essence of
what the future has reserved in this discipline: ‘‘Mathematics Is
Biology’s Next Microscope, Only Better; Biology Is Mathematics’
Next Physics, Only Better’’.
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effectiveness analysis with models of transmission dynamics to
address both the short- and long-term impact of resource
allocation, while also addressing parameter and model uncertainty
[44–47]. Traditional cost-effectiveness analyses are generally
performed as a one-time comparative analysis of interventions
for a cohort of individuals without considering transmission
dynamics. However, one-time analyses incorporate neither the
dynamic aspect of immunity in a population immunity nor the
evolutionary consequences of interventions upon hosts, vectors,
and pathogens, which in themselves modify the trade-off between
costs and benefits of interventions with time [46,47].
Indeed, the future directions of modeling pose an interesting
challenge. As the field of modeling expands, taking into account
biological and ecological details, incorporating dynamic and
evolutionary aspects, considering the short- and long-term benefits
and consequences, and incorporating uncertainty in parameters
and predictions, the need to clearly and properly state a model’s
results and predictions becomes paramount so that the insights
may inform policy.
Conclusion
Mathematical modeling and cost-effectiveness analysis are essential
tools for addressing research questions related to the control of
neglected vector-borne diseases. Modelers need to take into consider-
ation a variety of factors, such as pathogen and vector evolution,
combined intervention strategies, novel interventions, and the temporal
dynamics of disease transmission in order to accurately estimate the
benefits and costs of interventions, as well as to predict outcomes.
We have outlined approaches to model parameterization and
sensitivity analysis that are fundamental to the interpretation of
modeling results. We argue that sensitivity analyses are necessary
to handle uncertainty in disease systems, including our incomplete
knowledge of ‘‘true’’ parameter values. However, it is important to
keep in mind that models should only be as complicated as needed
to avoid unnecessary ‘‘pseudo-realism’’ derived from complex
models that cannot be parameterized [48]. Communication
among modelers, epidemiologists, ecologists, and molecular
biologists is essential for the development of realistic models that
take into account established knowledge to advance an under-
standing of systems and to inform public health decisions.
We advocate the use of mathematical models in the analysis of
control programs. Several steps in this process are active areas of
research, notably the merging of transmission dynamics with cost-
effectiveness analysis. As a future trend, we anticipate an increasing
partnership between theoretical and field researchers. Such
interactions would facilitate the development of a data-driven
model that could offer practical guidance to inform policy decisions.
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